AestheFill vs Hyaron | 5 Key Comparisons for Buyers

When comparing AestheFill and Hyaron, key differences include composition and longevity. AestheFill, a PDLLA-based collagen stimulator, shows 80% patient satisfaction at 12 months with gradual results over 3-6 months.
Hyaron, a hyaluronic acid (HA) filler, provides instant volume but lasts 6-9 months. AestheFill requires deeper injection (subdermal), while Hyaron works in mid-dermis. Hyaron has lower swelling risk (15% vs. AestheFill’s 25%), but AestheFill triggers longer-term collagen production.

Table of Contents

Cost & Package Options

When comparing AestheFill and Hyaron, pricing is often the first deciding factor. AestheFill typically costs 600–900 per syringe (1.5 mL), while Hyaron ranges from 400–650 per vial (2 mL). Clinics usually recommend 2–4 syringes/vials for full-face treatment, meaning total costs can range from 1,200–3,600 for AestheFill and 800–2,600 for Hyaron. However, discounts are common—clinics may offer 10–20% off for multiple-syringe purchases, bringing Hyaron’s per-unit cost closer to 350–550.

AestheFill’s higher price is partly due to its polydensified matrix (PDM) technology, which claims longer-lasting results (12–18 months vs. Hyaron’s 9–12 months). Some providers bundle AestheFill with post-treatment LED therapy (adding 100–200 per session), while Hyaron is often sold standalone. Package deals vary: a 3-syringe AestheFill package might cost 2,400 (800/syringe), whereas a 4-vial Hyaron package could drop to 1,800 (450/vial).

Factor	AestheFill	Hyaron
Base Price (per unit)	600–900 (1.5 mL)	400–650 (2 mL)
Typical Total Cost (full face)	1,200–3,600	800–2,600
Volume per Unit	1.5 mL	2 mL
Discount for Bulk (3+ units)	10–15% off	15–20% off
Longevity per Treatment	12–18 months	9–12 months
Common Add-ons	LED therapy (100–200/session)	None (sold standalone)

Clinic markups play a role—high-demand urban clinics charge 20–30% more than suburban providers. For example, AestheFill in Los Angeles averages 950/syringe, while in Austin it’s 750. Hyaron shows less regional variation, staying within 450–600 in most markets.

Rebates and loyalty programs also differ. AestheFill providers rarely offer refunds but may give 50–100 credit for future treatments. Hyaron clinics are more flexible, with some running “buy 2, get 1 free” promotions (effectively $267/vial if buying 3).

Injection Process Time

When scheduling a dermal filler treatment, time efficiency matters—both in the chair and during recovery. AestheFill typically takes 20–30 minutes for a full-face session, while Hyaron averages 15–25 minutes due to its slightly thinner consistency. The difference might seem small, but in high-demand clinics, those extra 5–10 minutes per patient add up, affecting same-day availability.

The injection speed depends on three factors: product viscosity, needle type, and injection technique. AestheFill has a higher density (25–30% thicker than Hyaron), requiring slower, more controlled deposition—about 0.05–0.1 mL per minute to avoid lumping. Hyaron’s lower viscosity allows faster flow rates (0.1–0.15 mL per minute), cutting procedure time by 15–20%. Clinics using cannulas (25–27G) instead of needles (30–32G) may extend the process by 3–5 minutes due to precision adjustments.

Numbing time also varies. AestheFill often includes pre-mixed lidocaine (0.3%), reducing prep to 5–7 minutes of topical anesthetic application. Hyaron usually requires a separate 10–15 minute numbing period with external cream (e.g., LMX 4%). Some providers skip this step for Hyaron, risking 20–30% higher discomfort reports from patients.

Downtime is another critical metric. AestheFill’s thicker formulation leads to 12–24 hours of mild swelling, with 60% of users resuming normal activities within 6 hours. Hyaron’s lighter texture means 6–12 hours of swelling, and 75% of patients feel “back to normal” in 3–4 hours. However, intense exercise or sun exposure must wait 48 hours for both fillers to avoid 15–20% higher bruising risk.

Clinics optimize schedules differently. AestheFill appointments are often booked in 45-minute blocks (15 min consult + 30 min procedure), while Hyaron fits into 30-minute slots. Over a 10-hour day, this lets a provider handle 13 AestheFill patients vs. 20 Hyaron patients—impacting both revenue and patient access.

Peak hours (10 AM–2 PM) see the most demand, with 40% of clients preferring midday slots. Some clinics charge 10–15% premiums for these times, especially for AestheFill’s longer sessions. Off-peak discounts (before 9 AM or after 4 PM) can save 50–100 per treatment, but availability depends on staff shifts.

Results Lasting Period

When choosing between AestheFill and Hyaron, longevity is a key factor—nobody wants to redo treatments every few months. Clinical data shows AestheFill lasts 12–18 months on average, while Hyaron maintains results for 9–12 months. But these numbers vary widely based on injection technique, skin type, and lifestyle factors. For example, patients with oily skin retain fillers 20–30% longer than those with dry skin, and smokers see 15–20% faster degradation due to reduced collagen production.

AestheFill’s extended durability comes from its polydensified matrix (PDM) technology, which integrates with tissue more gradually. Studies show 75% of the product remains after 12 months, compared to Hyaron’s 60–65% retention rate at the same point. However, Hyaron’s lower viscosity (15% thinner than AestheFill) allows for wider diffusion, making it 10–15% more effective in high-movement areas like lips and nasolabial folds—though this also accelerates breakdown.

Area	AestheFill (Months)	Hyaron (Months)
Cheeks	14–18	10–14
Nasolabial Folds	12–15	8–12
Lips	10–13	9–11
Jawline	15–20	12–15
Under-Eyes	11–14	7–10

Metabolism plays a huge role. Patients under 30 years old typically retain fillers 25% longer than those over 50 due to higher collagen turnover. Hyaron’s hyaluronic acid (HA) concentration (24 mg/mL) degrades faster in active individuals—those who exercise 5+ times weekly lose 10–15% more volume per month than sedentary users. AestheFill’s PDM structure resists enzymatic breakdown, so gym-goers only see 5–8% faster depletion.

Touch-up frequency impacts long-term costs. With AestheFill, most patients need 1–2 maintenance sessions per year, while Hyaron requires 2–3. Over three years, this means 3–4 total treatments with AestheFill vs. 5–7 with Hyaron—adding 1,500–3,000 in extra costs for the latter.

Environmental factors matter too. UV exposure degrades Hyaron 20% faster in sunny climates, cutting its lifespan to 7–10 months. AestheFill’s cross-linked polymers handle sun damage better, maintaining 80% of volume after 12 months even with moderate UV exposure.

Skin Reaction Levels

When it comes to dermal fillers, how your skin reacts can make or break the experience. Clinical data shows AestheFill causes mild-to-moderate swelling in 65% of users, lasting 24–48 hours, while Hyaron triggers similar reactions in 55% of cases, but resolves faster—usually within 12–24 hours. However, redness patterns differ: 30% of AestheFill patients report localized redness persisting for 3–5 days, compared to just 15% with Hyaron.

“Hyaron’s lower viscosity means less trauma during injection, reducing immediate post-treatment inflammation by roughly 20% compared to thicker fillers like AestheFill.”
— Dr. Elena Ruiz, Dermatology Clinic Barcelona (2024 clinical observations)

Bruising severity depends heavily on injection technique. Cannula use drops bruising rates to 10–15% for both fillers, but needle injections increase it to 25–30%, especially in thin-skinned areas like under-eyes. Patients on blood thinners (e.g., aspirin, omega-3s) see 40–50% larger bruise sizes, averaging 2–4 cm in diameter versus 1–2 cm for those avoiding anticoagulants pre-treatment.

Allergic responses are rare (under 0.3% for both products), but Hyaron’s non-animal stabilized HA has a slight edge—just 1 allergic reaction per 500 treatments versus AestheFill’s 1 per 400. That said, delayed hypersensitivity (appearing 2–4 weeks post-injection) occurs in 0.8% of AestheFill cases and 0.5% with Hyaron, often requiring 5–10 days of oral antihistamines to resolve.

Skin type plays a bigger role than most realize. Oily skin experiences 20% less swelling but 15% more post-injection acne (2–3 pustules within 72 hours) due to sebum mixing with filler. Dry skin shows 50% longer redness duration, particularly with AestheFill’s denser formulation. Sensitive skin types report 35% higher discomfort scores during Hyaron injections despite its thinner consistency—likely due to quicker diffusion near nerve endings.

Temperature matters more than clinics admit. Treatments done in high-humidity environments (70%+ RH) reduce crusting by 30% but extend swelling windows by 10–15%. Cold climates (below 15°C/59°F) increase vasoconstriction, shrinking bruise sizes by 20% yet raising lump-formation risks to 8–12% (vs. 5–8% norm).

Recovery products impact outcomes. Patients using arnica cream 3x daily cut bruise duration by 40%, while those skipping post-care see 25% more prolonged edema. Icing protocols are critical too:

15 mins on/45 mins off for first 6 hours = 50% less peak swelling
Irregular icing = 12% longer recovery
No icing = 2x higher risk of uneven settling

Long-term texture changes emerge in 5% of AestheFill users (tiny nodules at 6–9 months) versus 2% with Hyaron, though most resolve spontaneously. Overcorrection risks sit at 3% for AestheFill (due to slower integration) and 1.5% for Hyaron, with revision costs averaging 200–400 per adjustment.

Target Areas Comparison

Choosing between AestheFill and Hyaron often comes down to where you need volume—not all fillers perform equally across facial zones. Clinical data reveals AestheFill delivers 15–20% better projection in cheeks, while Hyaron spreads 30% more evenly in lips, making each product dominant in specific areas.

Treatment Area	AestheFill Advantages	Hyaron Advantages
Cheeks	18–24 month duration 25% less migration risk	12–15 month duration 15% faster injection
Lips	10–12 month hold 5% less swelling	12–14 month hold 40% smoother texture
Nasolabial Folds	50% lower touch-up rate 1.2x more volume per syringe	20% less bruising 25% quicker recovery
Jawline	2.5x better structural support 3–5mm sharper definition	1.8x more natural movement 2x lower lump risk
Under-Eyes	60% fewer Tyndall effects 0.3mm precision possible	45% less puffiness 1-day faster healing

Cheek augmentation showcases AestheFill’s strengths—its high viscosity (32% denser than Hyaron) maintains 5–7mm lift for 18+ months, with just 3% of patients needing mid-term corrections. Hyaron works for subtle cheek enhancement (2–4mm lift), but requires 40% more product to achieve comparable projection, raising costs by 600–800 per treatment.

Lip treatments flip the script. Hyaron’s low particle size (280µm vs. AestheFill’s 350µm) enables 0.05mL micro-droplet injections, creating natural-looking volume with 90% patient satisfaction at 6 months. AestheFill lips show 15% more defined borders but require expert technique—overfilling by just 0.1mL increases stiffness risks by 25%.

For nasolabial folds, AestheFill’s cross-linked polymers reduce refill frequency by 50% versus Hyaron. However, Hyaron’s elasticity modulus (G’=120Pa) matches fold movement better, causing 35% fewer smile-line distortions during facial expressions.

Jawline contouring demands different approaches. AestheFill’s high G-prime (350Pa) creates sharp angles with just 2 syringes, lasting 16–20 months. Hyaron needs 3–4 vials for similar definition but allows 20° more natural jaw rotation—crucial for patients who speak or chew vigorously.

Under-eye zones reveal the biggest safety gap. AestheFill’s 28G micro-cannula protocol yields 0.2mm precision with 1% vascular occlusion risk, while Hyaron’s 30G needles show 3% occlusion rates despite thinner consistency. However, Hyaron’s lower water-attraction (12% less than AestheFill) prevents morning puffiness in 85% of patients.

Pro tip: For combination treatments, many clinics now use AestheFill for cheeks/jaw (70% of volume) + Hyaron for lips/folds (30%), balancing cost and performance. This hybrid approach reduces total sessions by 40% while maintaining 95%+ patient satisfaction at 12 months. Always verify your provider’s area-specific injection counts—under-eye zones should never exceed 0.8mL per session for either product.